Timing for Free-Flap Reconstruction for Gustilo Type III Lower Limb Fractures: Systematic Review and Meta-analysis

Gustilo III型下肢骨折游离皮瓣重建的时机选择:系统评价和荟萃分析

阅读:1

Abstract

Despite improvements in surgical techniques, the optimal timing for free-flap reconstruction in Gustilo type III lower limb fractures remains controversial. Although existing interventions have shown positive outcomes, comprehensive data assessing the effect of timing on flap failure and infection rates are still limited. This systematic review and meta-analysis evaluated the impact of timing on the success of free-flap reconstructions in patients with Gustilo type III lower limb fractures. The included studies categorized reconstruction timing into 4 groups: immediate (within 72 h), early (72 h to 1 wk), delayed (1 wk to 42 d), and late (beyond 42 d). Outcomes of interest were infection and flap failure rates. A proportional meta-analysis was conducted to synthesize these outcomes, and meta-regression was used to detect significant differences across timing groups. A total of 26 studies involving 451 flap reconstructions were analyzed. No statistically significant differences were found in infection rates among the timing groups (P = 0.3331). Similarly, timing did not significantly influence flap failure rates (P = 0.0772). However, within the delayed reconstruction group, patients who received negative pressure wound therapy (NPWT) had a significantly lower flap failure rate (3%, 95% confidence interval: 1%-15%) compared with those who did not receive NPWT (13%, 95% confidence interval: 7%-23%; P = 0.0324). In conclusion, free-flap reconstructions for Gustilo type III fractures are safe and effective regardless of timing, with no significant differences in infection or failure rates. The findings also highlight the benefits of NPWT in delayed reconstructions, supporting its use to improve surgical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。